Celularity Inc. Announces $30 Million Private Placement Priced At-The-Market Under Nasdaq Rules
FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Month: May 2022
Outlook Therapeutics to Present at the H.C. Wainwright Global Investment Conference
ISELIN, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial…
Caladrius Biosciences to Present at the H.C. Wainwright Global Investment Conference
BASKING RIDGE, N.J., May 18, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Applied Molecular Transport Provides Strategy Update
Company streamlines to prioritize resources on key proprietary clinical programs, including plans to advance AMT-101…
Aeterna Zentaris to Present at the H.C. Wainwright Global Investment Conference
TORONTO, ONTARIO, May 18, 2022 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference
MALVERN, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention
AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference
BOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
VYNE Therapeutics to Present at HC Wainwright & Co. Global Investment Conference
BRIDGEWATER, N.J., May 18, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development
Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) FLORHAM PARK, N.J., May 18, 2022…
Surrozen Initiates Dosing in Phase 1 Clinical Trial of SZN-1326 for Moderate to Severe Ulcerative Colitis
SZN-1326 is a Fzd5-targeted Wnt-mimetic (SWAP) bi-specific antibody First part of three-part Phase 1/1b trial…
Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
NEEDHAM, Mass., May 18, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a late…
AGTC to Present at the H.C. Wainwright Global Investment Conference
GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 18, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
AIM ImmunoTech Provides Update on Ampligen Long COVID Development Program
AIM Chief Medical Officer David Strayer, MD AIM Chief Medical Officer David Strayer, MD Charles…
Immutep Appoints Leading Oncologists to its Clinical Advisory Board
SYDNEY, AUSTRALIA, May 18, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
BioSyent Releases Financial Results for Q1 2022
MISSISSAUGA, Ontario, May 18, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released…
Morphic Appoints Joanne Gibbons as Senior Vice President of Regulatory Affairs
Experienced Regulatory Leader with Record of Global and Regulatory Success Across Multiple Therapeutic Areas WALTHAM,…
Otonomy to Participate in the H.C. Wainwright Global Investment Conference
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
Avalo Therapeutics Announces First Patient Dosed in the Phase 2 PEAK Trial of AVTX-002 for the Treatment of Non-Eosinophilic Asthma (NEA)
Topline results expected 4Q2022 WAYNE, Pa. and ROCKVILLE, Md., May 18, 2022 (GLOBE NEWSWIRE) —…